Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

If you are wondering whether Exponent is a bargain or a trap at today’s price, you are not alone. This breakdown is designed to help you see what the market might be missing. The stock has slipped 1.6 ...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll ...

Exponent’s stock price has taken a beating over the past six months, shedding 26.7% of its value and falling to $81.90 per ...

Exponent's (NASDAQ:EXPO) stock up by 2.8% over the past month. Given its impressive performance, we decided to study the company's key financial indicators as a company's long-term fundamentals ...

Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net ...

Earnings from consulting firm Exponent (NASDAQ: EXPO) came in below expectations, and the company continues to see challenges heading into 2024. Investors are moving to the sidelines, sending shares ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. A general sense of optimism was ...

Fintel reports that on December 15, 2025, UBS maintained coverage of Exponent (NasdaqGS:EXPO) with a Neutral recommendation. Analyst Price Forecast Suggests 14.98% Upside As of December 6, 2025, the ...